Pulmonary embolismanticoagulationthrombolysisintermediate-riskhigh-riskembolectomy.1.Johnson AJ, Tillett WS. The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). J Exp Med 1952; 95(5): 449-64. doi: 10.1084/jem.95.5.449 PMID: 149277982.Fletcher AP, Sherry S, Alkjaersig N, Smyrniotis FE, Jick S. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1959; 38(7): 1111-9. doi: 10.1172/JCI103887 PMID: 136647863.Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990; 98(6): 1473-9. doi: 10.1378/chest.98.6.1473 PMID: 21231524.Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353(9162): 1386-9. doi: 10.1016/S0140-6736(98)07534-5 PMID: 102272185.Jerjes-Sanchez C, Ramírez-Rivera A, de Lourdes García M, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis 1995; 2(3): 227-9. doi: 10.1007/BF01062714 PMID: 106080286.Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347(15): 1143-50. doi: 10.1056/NEJMoa021274 PMID: 123748747.Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370(15): 1402-11. doi: 10.1056/NEJMoa1302097 PMID: 247166818.Jimenez D, Martin-Saborido C, Muriel A, et al. Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: Systematic review and network meta-analysis. Thorax 2018; 73(5): 464-71. doi: 10.1136/thoraxjnl-2017-210040 PMID: 291333519.Sadeghipour P, Jenab Y, Moosavi J, et al. Catheter-directed thrombolysis vs. anticoagulation in patients with acute intermediate-high–risk pulmonary embolism. JAMA Cardiol 2022; 7(12): 1189-97. doi: 10.1001/jamacardio.2022.3591 PMID: 3626030210.Bashir R, Foster M, Iskander A, et al. Pharmacomechanical catheter-directed thrombolysis with the bashir endovascular catheter for acute pulmonary embolism. JACC Cardiovasc Interv 2022; 15(23): 2427-36. doi: 10.1016/j.jcin.2022.09.011 PMID: 3612124411.Kucher N, Boekstegers P, Müller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129(4): 479-86. doi: 10.1161/CIRCULATIONAHA.113.005544 PMID: 2422680512.Avgerinos ED, Jaber W, Lacomis J, et al. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism. JACC Cardiovasc Interv 2021; 14(12): 1364-73. doi: 10.1016/j.jcin.2021.04.049 PMID: 3416767713.Sista AK, Horowitz JM, Tapson VF, et al. Indigo aspiration system for treatment of pulmonary embolism. JACC Cardiovasc Interv 2021; 14(3): 319-29. doi: 10.1016/j.jcin.2020.09.053 PMID: 3345429114.Toma C, Jaber WA, Weinberg MD, et al. Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. EuroIntervention 2023; 18(14): 1201-12. doi: 10.4244/EIJ-D-22-00732 PMID: 3634970215.Horowitz JM, Jaber WA, Stegman B, et al. Mechanical thrombectomy for high-risk pulmonary embolism: Insights from the US cohort of the FLASH registry. JSCAI 2023; p. 101124.16.Iannaccone M, Franchin L, Russo F, et al. Mortality across treatment strategies in intermediate-to-high risk pulmonary embolism in the modern era: A meta-analysis of observational studies and RCTs. Int J Cardiol 2023; 387: 131127. doi: 10.1016/j.ijcard.2023.131127 PMID: 37355238